Pregnancy And Fertility Testing Market is foreseen to reach 594.6 million in 2025, up from 423.7 million USD in 2020, with a CAGR of 8.4% during the outlook period 2020-2025.

Pregnancy and fertility tests are used to detect the presence of reproductive hormones, such as follicle-stimulating hormone or luteinizing hormone. The female reproductive system is complex in structure and function. From birth to senescence, the organs of the female reproductive system work in concert with each other, with the brain, and with other endocrine organs. Because the functioning of the female reproductive system has such a huge impact on the life of every woman, increasing importance is being placed on the active participation of women in understanding their own health care needs, such as determining pregnancy and fertility.

Recent Developments

June 17, 2020, Modern Fertility introduced its pregnancy and ovulation tests, as well as a mobile application to integrate all the information related to fertility in women.

In December 2018, Concepta Diagnostics launched a new tool to monitor ovulation. The way it works is that a user enters each new cycle in the app from the first day of their period and records the days of bleeding. On the eighth day of a woman's cycle, the monitor will order an LH test. Women test themselves in the monitoring system and then enter the results into the app.

In September 2018, Mira launched a device for more accurate home fertility tests. Mira has launched a new device that aims to help women who have difficulty conceiving. The Mira Fertility system offers personalized cycle prediction by measuring levels of fertility hormones in urine samples and tells women which days they are fertile. The system is more advanced and accurate than existing home test kits, according to the company, which can be difficult to read and are not personalized for the individual.

Browse for full report @ https://www.marketdataforecast.com/market-reports/pregnancy-and-fertility-testing-market

Market Growth

OPKs or ovulation prediction kits are used to detect the exact day of ovulation of a woman who is planning her pregnancy. There are many types of ovulation predictor kits on the market. Most kits work by measuring luteinizing hormone (LH) in the urine. LH levels rise 24 to 36 hours before ovulation. The high level of LH indicates that the release of the egg (ovulation) usually occurs 12 to 24 hours after the test turns positive. According to the Centers for Disease Control, one in eight couples have difficulty conceiving or maintaining a pregnancy due to age, health issues, or other factors. This indicates that there is a need in the market for accurate and cost-effective ovulation monitors. As OPK provides cost-effective fertility testing, demand increases for the pregnancy and fertility testing market.

Drivers

The escalating acquisition of home diagnostic test kits is driving the growth of the pregnancy and fertility testing market as these products are not complicated in terms of usage and prevent patients from going to laboratories. In addition, these products are also cost-effective and can be easily used by the patient at home. Hence, increasing demand for home diagnostic devices is a major factor that will drive the market tremendously in the years to come. In addition, increased healthcare spending is fueling the growth of the rapid pregnancy and female fertility testing markets around the world as several countries spend large sums on healthcare that provides better accessibility to medical treatment for advanced patients. Also, the increasing prevalence of various diseases, and subsequently the introduction of diagnostic products with advanced functionality, is expected to stimulate the demand for rapid fertility and pregnancy test kits.

Ask for a sample report @ https://www.marketdataforecast.com/market-reports/pregnancy-and-fertility-testing-market/request-sample

Restraints

The unproven accuracy of urine-based ovulation monitors in women with PCOS and the lesser accuracy in confirming ovulation using ovulation prediction kits are factors that are expected to slow the market growth in the coming years. The increased cost and presence of alternative diagnostic methods are likely to restrain the robust growth of the fertility and pregnancy testing market. For example, commercially available intermediates are expensive compared to test strips. Therefore, patients mainly opt for the latter, which may lead to reduced adoption of intermediates. In addition, the preference for various tests, such as blood tests and laboratory tests, is also hampering the growth of the pregnancy and fertility testing market, as these are carried out by trained professionals and provide accurate results and therefore hence, they are highly preferred by patients. In addition, limited knowledge of these products, especially in developing economies, will also hamper the growth of the market.

COVID–19 Impact on Pregnancy and Fertility Testing Market

There is limited evidence for the effects of SARS-CoV-2 on gametes. Human Reproductive Societies have published practice guidelines during the coronavirus pandemic that include the implementation of mitigation practices and infection control protocols in fertility care units. The restrictions imposed at the start of the pandemic were successful in containing the spread of infection, allowing the eventual resumption of assisted reproduction treatments under new practice guidelines. Canada has dedicated funds to support research on COVID-19, including a surveillance study to monitor outcomes of coronavirus during pregnancy and assisted reproduction. There should be an ongoing assessment of new evidence to carefully adjust recommendations for the management of patients during assisted reproduction technologies (ART) and pregnancy.

Market Segmentation

By Product

Ovulation Prediction Kits (OPK)
Fertility Monitors
Male Fertility Testing Products

In 2019, the ovulation prediction kits segment represented the majority of the pregnancy and fertility testing market. Much of this can be attributed to their low cost and high efficiency, their strong preference for these kits, and the increasing average age of first pregnancies in women.

By Mode of purchase
Prescription- Based
Non-Prescription/OTC-Based
In 2019, the OTC segment accounted for a larger share of the market. The large proportion can be attributed to factors such as the growing patient preference for remote and home monitoring, the availability of e-commerce, the confidentiality and accessibility of test results and the increasing initiatives taken by major players market to develop user-friendly and precise products.

By Application

Female Fertility Testing
Male Fertility Testing
In 2019, the female fertility testing segment held a larger share of the market. The large proportion can be attributed to factors such as declining female fertility rates, the availability of a wide range of fertility testing options, and the high cost of IVF procedures.

By End User

Home Care Settings
Hospitals
Fertility Clinics
Others
In 2019, the home care setting segment accounted for the majority of the global pregnancy and fertility testing market. This high proportion can be attributed to declining fertility rates for both women and men, the growing need for continuous monitoring of health conditions and the growing preference for remote and home monitoring.

Regional Analysis

The Americas have dominated the global pregnancy and fertility testing market due to the growing awareness of pregnancy testing methods and improved fertility rates. Further, the increasing prevalence of teenage pregnancy and the presence of major players in the market create a favorable environment for the growth of the market in the Americas.

In 2019, Europe held the second largest share of the fertility testing market. The growth of the market is attributed to rising healthcare spending, advancements in technology, and increasing infertility and gynecological disorders. According to the European Commission, the live birth rate per woman in Europe is 1.8, which is very low. The birth rate decreases year by year due to infertility. Germany held the largest share of the European fertility testing market.

Asia Pacific (APAC) is anticipated to represent the quickest share during the forecast period. The growth of the pregnancy and ovulation testing market in Asia-Pacific is attributed to the increasing need for rapid and stand-alone testing and the increasing age of first pregnancy. In addition, the increase in the birth rate and a significant increase in the young population are driving the growth of the market in this area.On the other hand, the Middle East and Africa is estimated to have the smallest share of the pregnancy and fertility testing market due to the low economic development, especially in Africa.

Key Players

The key players in the pregnancy and fertility test market include SPD Swiss Precision Diagnostics GmbH (Switzerland), and Church & Dwight Co., Inc. (U.S.),. Other players in this market include Valley Electronics GmbH (Germany), Geratherm Medical AG (Germany), Prestige Brands Holdings, Inc. (U.S.), Hilin Life Products, Inc (US), Fairhaven Health, LLC (U.S.), Fertility Focus Limited (UK), bioZhena Corporation (US), TaiDoc Technology Corporation (Taiwan), UEBE Medical GmbH (Germany), AdvaCare Pharma (US), Ava (Switzerland), Babystart Ltd. (UK), and Sensiia (UK).